TRAVERE THERAPEUTICS, INC. Increase (Decrease) in Due to Related Parties
TRAVERE THERAPEUTICS, INC. (TVTX) reported Increase (Decrease) in Due to Related Parties of $0 for the 31-month period ending 2013-09-30, per its 10-Q filed 2013-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2015-07-09
- 2013-09-30: Increase (Decrease) in Due to Related Parties 9 month $0.00; Increase (Decrease) in Due to Related Parties 31 month $0.00.
- 2012-09-30: Increase (Decrease) in Due to Related Parties 9 month -$2.80K.
| Period end | Increase (Decrease) in Due to Related Parties 9 month | Increase (Decrease) in Due to Related Parties 31 month |
|---|---|---|
| 2013-09-30 | $0.00 10-Q · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 |
| 2012-09-30 | -$2.80K 10-Q/A · filed 2015-07-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |